학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 155건 | 목록 1~10
Academic Journal
Shahzad M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; H. Lee Moffitt Cancer Center, Tampa, Florida, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Amin MK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Bellman P; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Al-Ramahi J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Noor J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Vyas A; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mahmoudjafari Z; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; McGuirk M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; DeJarnette S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Abhyankar S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.
Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE
Academic Journal
Ahmed N; University of Kansas Cancer Center, Westwood, Kansas, United States.; Wesson W; University of Kansas Cancer Center, Westwood, Kansas, United States.; Lutfi F; University of Kansas Medical Center, Westwood, Kansas, United States.; Porter DL; University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States.; Bachanova V; University of Minnesota, Minneapolis, Minnesota, United States.; Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Perales MA; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Maziarz RT; Knight Cancer Institute, Portland, Oregon, United States.; Brower J; University of Pennsylvania, Philadelphia, Pennsylvania, United States.; Shah GL; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Chen AI; Knight Cancer Institute, Oregon Health & Science University.; Oluwole OO; Vanderbilt University Medical Center, Nashville, Tennessee, United States.; Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States.; Bishop MR; University of Chicago, Chicago, Illinois, United States.; McGuirk JP; University of Kansas Cancer Center, Westwood, Kansas, United States.; Riedell PA; The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois, United States.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
McGuirk M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Shahzad M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Amin MK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Khan MA; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Bellman P; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Mudaranthakam DP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; DeJarnette S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Lutfi F; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Bansal R; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Abdelhakim H; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Gorsline C; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Shoemaker DM; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Abhyankar SH; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.; Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America. Electronic address: mmushtaq@kumc.edu.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9309923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5492 (Electronic) Linking ISSN: 09663274 NLM ISO Abbreviation: Transpl Immunol Subsets: MEDLINE
Academic Journal
Zanwar S; Division of Hematology, Department of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.; Sidana S; Stanford University School of Medicine, Stanford, CA, USA.; Shune L; The University of Kansas Medical Center, Kansas City, KS, USA.; Puglianini OC; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Pasvolsky O; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gonzalez R; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.; Afrough A; UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.; Kaur G; UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.; Davis JA; Medical University of South Carolina, Charleston, SC, USA.; Herr M; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Hashmi H; Medical University of South Carolina, Charleston, SC, USA.; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Forsberg P; University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Sborov D; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.; Anderson LD Jr; UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA.; McGuirk JP; The University of Kansas Medical Center, Kansas City, KS, USA.; Wagner C; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.; Lieberman-Cribbin A; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Rossi A; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Freeman CL; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Locke FL; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.; Richard S; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.; Lin Y; Division of Hematology, Department of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.; Patel KK; Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. KPatel1@mdanderson.org.; Kumar SK; Division of Hematology, Department of Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. Kumar.Shaji@mayo.edu.; Hansen DK; Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Doris.Hansen@moffitt.org.
Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Academic Journal
Dima D; Department of Hematology/Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA. dimad@ccf.org.; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA. dimad@ccf.org.; Abdallah AO; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS, USA.; Davis JA; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, USA.; Awada H; Department of Hematology/Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.; Goel U; Department of Hematology/Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.; Rashid A; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS, USA.; DeJarnette S; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS, USA.; Anwer F; Department of Hematology/Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Shune L; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS, USA.; Raza S; Department of Hematology/Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Mahmoudjafari Z; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS, USA.; Williams L; Department of Hematology/Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.; Faiman B; Department of Hematology/Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.; McGuirk JP; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS, USA.; Sauter CS; Department of Hematology/Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.; Ahmed N; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS, USA.; Khouri J; Department of Hematology/Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.; Hashmi H; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS, USA. hamzahashmi87@hotmail.com.; Division of Hematology/Oncology, Medical University of South Carolina, Charleston, SC, USA. hamzahashmi87@hotmail.com.; Memorial Sloan Kettering Cancer Center, New York, NY, USA. hamzahashmi87@hotmail.com.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Academic Journal
Ahmed N; Hematologic Malignancies and Cellular Therapeutics University of Kansas Cancer Center.; Oluwole O; Medicine, Hematology and Oncology Vanderbilt University Medical Center.; Mahmoudjafari Z; Hematologic Malignancies and Cellular Therapeutics University of Kansas Cancer Center.; Suleman N; Hematologic Malignancies and Cellular Therapeutics University of Kansas Cancer Center.; McGuirk JP; Hematologic Malignancies and Cellular Therapeutics University of Kansas Cancer Center.
Publisher: International Academy for Clinical Hematology Country of Publication: England NLM ID: 101759455 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0048 (Electronic) Linking ISSN: 25900048 NLM ISO Abbreviation: Clin Hematol Int Subsets: PubMed not MEDLINE
Academic Journal
Dreyling M; Department of Medicine, Medical Clinic III, Ludwig-Maximilian-University Hospital, Munich, Germany.; Fowler NH; The University of Texas MD Anderson Cancer Center, Houston, TX.; BostonGene, Waltham, MA.; Dickinson M; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Martinez-Lopez J; Hospital 12 De Octubre, Complutense University, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.; Kolstad A; Oslo University Hospital, Oslo, Norway.; Butler J; Royal Brisbane Hospital, Herston, QLD, Australia.; Ghosh M; Division of Hematology/Oncology, Michigan Medicine University of Michigan, Ann Arbor, MI.; Popplewell L; City of Hope Comprehensive Cancer Center, Duarte, CA.; Chavez JC; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL.; Bachy E; Clinical Hematology, Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France.; Kato K; Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Harigae H; Department of Hematology, Tohoku University Hospital, Sendai, Japan.; Kersten MJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands, on behalf of Stichting Hemato-Oncologie voor Volwassenen Nederland/Lunenburg Lymphoma Phase I/II Consortium.; Andreadis C; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.; Riedell PA; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.; Ho PJ; Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.; Pérez-Simón JA; Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla Consejo Superior de Investigaciones Cientificas, Universidad de Sevilla, Seville, Spain.; Chen AI; Oregon Health and Science University, Portland, OR.; Nastoupil LJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; von Tresckow B; Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; María Ferreri AJ; Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Teshima T; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.; Patten PEM; Comprehensive Cancer Centre, King's College London, London, United Kingdom.; Department of Haematology, King's College Hospital, London, United Kingdom.; McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer l Center, Westwood, KS.; Petzer AL; Internal Medicine I, Ordensklinikum Linz Barmherzige Schwestern-Elisabethinen, Linz, Austria.; Offner F; Universitair Ziekenhuis Gent, Ghent, Belgium.; Viardot A; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli,' Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.; Malladi R; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Paule I; Novartis Pharma AG, Basel, Switzerland.; Zia A; Novartis Pharma AG, Basel, Switzerland.; Awasthi R; Novartis Institutes for BioMedical Research, East Hanover, NJ.; Han X; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Germano D; Novartis Pharma AG, Basel, Switzerland.; O'Donovan D; Novartis Pharmaceuticals Corporation, Dublin, Ireland.; Ramos R; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Maier HJ; Novartis Pharma AG, Basel, Switzerland.; Masood A; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Thieblemont C; Service d'hémato-oncologie, Hôpital Saint-Louis, Paris, France.; Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] McGuirk JP
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어